Intel's 13F Reveals a 1.29 Million-Share IREN Stake — While a $6 Billion Funding Gap Waits in the Wings
Published on 11/17/2026 at 19:50 | Editorial boerse-global.deIREN shares slipped 4.1% on Tuesday evening as a broader selloff swept through technology and AI infrastructure names. The move put a fine point on the question investors now face: is the company's already-contracted growth enough to justify the capital it still has to raise?
A regulatory filing offered a separate, more encouraging data point the same day. Intel disclosed a holding of 1.29 million IREN shares worth roughly $52.75 million, per its SEC Form 13F. The position is dated September 30 — a snapshot of a prior quarter, not evidence of a purchase at today's prices. That distinction matters for anyone reading the disclosure as a fresh vote of confidence.
A backlog above $20 billion, and a schedule under scrutiny
The contract base is substantial. IREN's order book stands at more than $20 billion, with about two-thirds of it tied to customers carrying investment-grade credit ratings. The Microsoft agreement alone accounts for $9.7 billion, and IREN has delivered the first 50 MW of the 200 MW committed at its Childress site.
Delivery, not signatures, is where the story turns. IREN pushed back its target of more than $4 billion in annualized recurring revenue — now expected in January 2027, with a possible slip into February — after a Microsoft-requested network adjustment at the Texas facility and delays on the supplier side. The company had already flagged an August contract with an unnamed AI lab; The Information subsequently reported that Anthropic holds an unannounced multi-year cloud deal with IREN. That remains a reported possibility rather than a confirmed attribution.
Should investors sell immediately? Or is it worth buying IREN?
The capex math carries a caveat
For fiscal 2027, IREN trimmed its capital expenditure forecast to $20 billion from a prior $25–30 billion range. Of the remaining planned spend, $9 billion is covered by liquid funds, committed financing and prepayments. The other $6 billion is to be sourced from additional channels — explicitly contingent on market conditions.
That split deserves careful reading. Committed capital and capital still being pursued do not carry the same degree of certainty, and lumping the entire build-out together as fully financed would misstate the picture. Treating all of it as unfunded would be equally wrong. The real test is whether IREN can raise the remainder on terms that preserve the economics of the expansion; a signed financing alone would say little without knowing its conditions.
Operating momentum, with a loss beneath it
The cloud business is already a meaningful contributor. AI cloud services generated $200 million in revenue in the first quarter of fiscal 2027, against $228 million total. Adjusted EBITDA came in at $66 million — alongside a net loss of $263 million.
Those figures point in different directions, and both belong in the assessment. Positive adjusted EBITDA does not mean the build-out can be funded from operations; the investment plan still requires its own review of available and outstanding capital.
Morningstar, for its part, flags supplier delays and financing risk in its more cautious valuation while still projecting average annual revenue growth above 120% over five years. The research firm expects free cash flow to stay negative for at least five more years and describes valuation uncertainty as very high.
Two dates that will settle the debate
Intel's disclosed stake is its own news impulse, but it does not refute those risks. What matters for IREN is converting contracted demand into delivered capacity — and paying for the build-out that gets it there. The next concrete checkpoints are the January 2027 annualized revenue target, possibly slipping to February, and binding progress on the additional financing. Until then, funding and execution have to be judged side by side; improvement on one front alone would not cancel the risk on the other.
Ad
IREN Stock: New Analysis - 17 November
Fresh IREN information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
